Psychiatry and Clinical Psychopharmacology aims to provide an international platform for the publication and exchange of high-quality scholarly research across psychiatry, clinical neuroscience, and psychopharmacology. The journal is committed to advancing clinical knowledge, therapeutic innovation, and mental health research that addresses contemporary challenges and emerging developments in psychiatric care.

The journal welcomes original research articles, review papers, clinical case studies, theoretical studies, and interdisciplinary works that contribute to the advancement of psychiatry, pharmacology, neuroscience, and mental health. It encourages researchers, clinicians, and mental health professionals to share significant findings, clinical insights, and conceptual frameworks that support global scholarly discussions and evidence-based practice.

Scope of the Journal

Psychiatry and Clinical Psychopharmacology covers a broad range of research areas, including but not limited to:

• • Clinical Psychiatry
• • Clinical Psychopharmacology
• • Neuropsychiatric Disorders
• • Neuroscience & Neuropharmacology
• • Translational Research
• • Pharmacotherapy & Clinical Trials
• • Neurobiology of Psychiatric Disorders
• • Pharmacogenomics & Personalized Medicine
• • Public Mental Health
• • Child & Adolescent Psychiatry
• • Geriatric Psychiatry
• • Psychosomatic Medicine
• • Forensic Psychiatry
• • Neuroimaging & Brain Stimulation
• • Mental Health Policy & Services
• • Interdisciplinary & Emerging Research Areas

The journal encourages contributions that bridge disciplinary boundaries and foster collaboration among researchers from diverse academic backgrounds. Studies employing theoretical, empirical, qualitative, and quantitative methodologies are welcomed, provided they demonstrate academic rigor, originality, and relevance to the broader research community in psychiatry and clinical psychopharmacology.

Through a rigorous peer-review process and commitment to ethical publishing practices, Psychiatry and Clinical Psychopharmacology seeks to support the dissemination of impactful research and contribute to the advancement of global academic knowledge in mental health and clinical neuroscience.